A detailed history of Nixon Peabody Trust CO transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 2,250 shares of ALNY stock, worth $552,240. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,250
Previous 3,300 31.82%
Holding current value
$552,240
Previous $801,000 22.85%
% of portfolio
0.05%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$233.81 - $287.01 $245,500 - $301,360
-1,050 Reduced 31.82%
2,250 $618,000
Q4 2023

Feb 09, 2024

BUY
$151.41 - $196.57 $272,538 - $353,826
1,800 Added 120.0%
3,300 $631,000
Q3 2021

Nov 04, 2021

SELL
$169.75 - $207.73 $84,875 - $103,865
-500 Reduced 25.0%
1,500 $283,000
Q4 2019

Jan 24, 2020

BUY
$74.51 - $124.23 $149,020 - $248,460
2,000 New
2,000 $230,000
Q2 2018

Jul 30, 2018

SELL
$88.31 - $107.8 $176,620 - $215,600
-2,000 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$72.53 - $118.27 $145,060 - $236,540
2,000
2,000 $235,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Nixon Peabody Trust CO Portfolio

Follow Nixon Peabody Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.